Optimal approach against symptomatic degenerative joint disease and lower back pain.

Mandatory Information

Harpavit film-coated tablets

Area of application:

Supportive treatment of degenerative disorders of the musculoskeletal system in adults.

Contains Lactose and Sucrose (sugars).

For risks and side effects, please ask your doctor and pharmacist.

Less Pain, More Mobility!

  • Fichier 3 Treatment of osteoarthritis and lower back pain.
    Relieves osteoarthritis and slows down the damage of cartilage tissue.
    Relieves lower back pain. (LBP)
  • Fichier 4 Alleviation of arthritis pain.
    Relieves arthritis-related joint pain, swelling and inflammation.
  • Fichier 5 Inhibition of cartilage degradation and bone loss.
    Maintains healthy cartilage and bone; and contributes to mature bone.

Four main biological activities of Devil’s claw root for the treatment of joint disease.

Pharmacological effects:

• Analgesic effects

Proven in various thermally, chemically and mechanically induced in vivo pain tests in rats.

• Anti-inflammatory effects

Demonstrated by numerous in vivo investigations: Inhibiting of cytokines (IL-1β, IL-6 and TNF-α) involved in the pathogenesis of degenerative joint disease and immune modulation.

• Chondroprotective effects

Inhibition of matrix metalloproteinases and elastase.

• Antioxidative effects

Inhibiting the release of reactive oxygen specifically damaging membrane lipids, proteins and DNA and RNA.

Advantages of Harpavit

  • Fichier 2 Contains a well proven medicinal plant that has been traditionally used for decades to treat chronic lower back and joint pain.
  • Fichier 2 Scientifically proven anti-inflammatory and analgesic effect.
  • Fichier 2 Continous reduction of pain symptoms, significant overall improvement in long-term use.
  • Fichier 2 Allows a markedly reduced dose of chemical antirheumatic agents.
  • Fichier 2 Well-tolerated anti-inflammatory herbal root extract, to return to the normal activities of everyday life.

Devil’s Claw is a well-established and traditionally used medicinal herb listed in major herbal pharmacopeias

European Community Herbal Monograph (EMEA / HMPC) British Herbal Pharmacopoeia (BP)
European Scientific Cooperative on Phytotherapy (ESCOP) Pharmacopée Française
German Commission E monograph (BGA) Health Canada : Natural Health Product Ingredient DB‧
German Homeopathic Pharmacopoeia (HAB 34) US Pharmacopeial Conventions : Herbal Medicines Compendium